UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 7, 2002
Genetronics Biomedical Corporation
| Delaware | 0-29608 | 33-0969592 | ||
(State or other jurisdiction |
(Commission
|
(IRS Employer |
||
of incorporation) |
File Number)
|
Identification No.) |
||
11199 Sorrento Valley Road, San Diego California |
92121-1334 |
|||
(Address of principal executive offices) |
(Zip Code) |
|||
Registrant’s telephone number, including area code (858) 597-6006
Not Applicable
| Item 5. Other Events. | ||||||||
| Item 7. Financial Statements and Exhibits. | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 5. Other Events.
On June 7, 2002, Genetronics Biomedical Corporation issued a press release related to the closing of a private placement of special warrants. The first group of special warrants were sold at a price of $0.42 per special warrant and the second group of special warrants were sold at a price of $0.47 per share. The sale of special warrants yielded gross proceeds of $4,300,000. Exhibit 99.1 is the press release issued to announce the closing of the sale of the special warrants.
Item 7. Financial Statements and Exhibits.
| Exhibit | ||
| No. | Description | |
99.1 |
Press release issued June 7, 2002 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Genetronics Biomedical Corporation | ||
| | ||
| By: | /s/ Avtar Dhillon | |
| Avtar Dhillon, Chief Executive Officer |
||
EXHIBIT INDEX
| Exhibit | ||
| No. | Description | |
99.1 |
Press release issued June 7, 2002 |